Earth Science Tech Inc. (OTC: ETST) announced fiscal year 2026 results for the year ended March 31, 2026, demonstrating growth across key financial metrics as the company continues to execute its diversified holdings model spanning healthcare, pharmaceuticals, telemedicine, real estate, and consumer businesses. Revenue increased 8% to $35.7 million, gross profit rose 5% to $25.5 million, net income grew 11% to $3.6 million, and total assets increased 27% to $9 million.
CEO Giorgio R. Saumat attributed the results to ETST's efforts to fully integrate the patient experience across telemedicine to pharmacy to fulfillment. The company operates as a diversified holding company focused on the health and wellness sector, with a principal operating strategy of building a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. Its healthcare operations are supported by investments in real estate and asset management activities and a consumer products business.
The core of the company's value proposition is the seamless integration of patient care, from consultation to fulfillment, achieved through the synergy of specialized subsidiaries. This end-to-end platform connecting telemedicine, pharmacy, and fulfillment represents a significant shift in how patients access healthcare services, potentially reducing costs and improving outcomes by streamlining the care delivery process.
The implications for the healthcare industry are substantial. By integrating these services, Earth Science Tech aims to eliminate common inefficiencies such as fragmented communication between providers and pharmacies, delays in prescription fulfillment, and lack of coordinated patient support. For patients, this could translate into faster access to medications, more personalized care, and a simplified healthcare journey. For the industry, the model may set a new standard for vertical integration in healthcare, encouraging other companies to adopt similar approaches to remain competitive.
ETST's growth in assets, up 27% to $9 million, indicates the company is investing in infrastructure to support its integrated platform. The 8% revenue increase and 11% net income growth suggest the strategy is gaining traction, though the company faces challenges in scaling operations and navigating regulatory complexities across different healthcare segments.
For more details on Earth Science Tech's financial results and strategy, visit the company's newsroom at https://nnw.fm/ETST. Additional information is available at www.EarthScienceTech.com.
